Clinical and Molecular Hepatology

"Radioembolization"

Correspondence

Hepatic neoplasm

Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”: Moon Haeng Hur, Yoon Jun Kim; Clin Mol Hepatol 2025;31(1):e93-e95.
Published online November 6, 2024; DOI: https://doi.org/10.3350/cmh.2024.0943

3,927 View
50 Download

Letter to the Editor

Hepatic neoplasm

Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis: Hang Li, Hua Lu, Xi-Ping Shen, Xiao-Song Li; Clin Mol Hepatol 2025;31(1):e3-e4.
Published online October 7, 2024; DOI: https://doi.org/10.3350/cmh.2024.0832

Citations

Citations to this article as recorded by

Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
Moon Haeng Hur, Yoon Jun Kim
Clinical and Molecular Hepatology.2025; 31(1): e93. CrossRef

4,772 View
62 Download
Crossref

Editorial

Hepatic neoplasm

Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”: Jin Hyoung Kim, Gun Ha Kim, Dong Il Gwon; Clin Mol Hepatol 2024;30(4):659-662.
Published online July 17, 2024; DOI: https://doi.org/10.3350/cmh.2024.0516

Citations

Citations to this article as recorded by

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Ramanpreet Singh, Mina S. Makary
Journal of Gastrointestinal Cancer.2025;[Epub] CrossRef

3,987 View
93 Download
1 Web of Science
Crossref

Original Article

Hepatic neoplasm

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis: Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim; Clin Mol Hepatol 2023;29(3):763-778.
Published online May 30, 2023; DOI: https://doi.org/10.3350/cmh.2023.0076

Background/Aims
Transarterial radioembolization (TARE) has shown promising results in treating advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). However, whether TARE can provide superior or comparable outcomes to tyrosine kinase inhibitor (TKI) in patients with HCC and PVTT remains unclear. We compared the outcomes of TARE and TKI therapy in treatment-naïve patients with locally advanced HCC and segmental or lobar PVTT.
Methods
This multicenter study included 216 patients initially treated with TARE (n=124) or TKI (sorafenib or lenvatinib; n=92) between 2011 and 2021. Baseline characteristics were balanced using propensity score matching (PSM) or inverse probability of treatment weighting (IPTW). The primary outcome was overall survival (OS). The secondary outcomes included progression-free survival (PFS) and
objective
response rate (ORR).
Results
In the unmatched cohort, the median OS of the TARE and TKI groups were 28.2 and 7.2 months, respectively (p<0.001), and the TARE group experienced significantly and independently longer OS compared to the TKI group (adjusted hazard ratio=0.41, 95% confidence interval=0.28–0.60, p<0.001). Similar results were observed in the study cohorts balanced with IPTW (p=0.003) or PSM (p=0.004). Although PFS was comparable between the two groups, the TARE group showed a trend of prolonged PFS in a subpopulation of patients with Vp1 or Vp2 PVTT (p=0.052). In the matched cohorts, the ORR of the TARE group was 53.0–56.7%, whereas that of the TKI group was 12.3–15.0%.
Conclusions
For patients with advanced HCC with segmental or lobar PVTT and well-preserved liver function, TARE may provide superior OS compared to sorafenib or lenvatinib.

Citations

Citations to this article as recorded by

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Ramanpreet Singh, Mina S. Makary
Journal of Gastrointestinal Cancer.2025;[Epub] CrossRef
Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis
Youngsu Park, Yuri Cho, Seung Up Kim, Aryoung Kim, Hyunjae Shin, Hyo-Cheol Kim, In Joon Lee, Gyoung Min Kim, Dongho Hyun, Yunmi Ko, Jeayeon Park, Jae Woong Yoon, Gyung Sun Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan
Diagnostic and Interventional Imaging.2025;[Epub] CrossRef
Transarterial radioembolization challenges immunotherapy as first-line care for hepatocellular carcinoma with portal vein tumor thrombosis
Anna Pellat, Maxime Barat
Diagnostic and Interventional Imaging.2025;[Epub] CrossRef
Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study
Bo Hyun Kim, Hee Chul Park, Tae Hyun Kim, Young-Hwan Koh, Jung Yong Hong, Yuri Cho, Dong Hyun Sinn, Boram Park, Joong-Won Park
JHEP Reports.2024; 6(4): 100991. CrossRef
Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim
Yonsei Medical Journal.2024; 65(7): 371. CrossRef
Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
Yuri Cho, Bo Hyun Kim, Young-Suk Lim
Digestive Disease Interventions.2024; 08(03): 169. CrossRef
Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence
Yaduo Li, Ningning Fan, Xu He, Jianjun Zhu, Jie Zhang, Ligong Lu
Journal of Hepatocellular Carcinoma.2024; Volume 11: 1429. CrossRef
Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report
Li-Cong Liang, Wen-Sou Huang, Zhao-Xiong Guo, Hong-Ji You, Yong-Jian Guo, Ming-Yue Cai, Li-Teng Lin, Guo-Ying Wang, Kang-Shun Zhu
World Journal of Gastroenterology.2024; 30(36): 4071. CrossRef
Transarterial intervention therapy combined with systemic therapy for HCC: a review of recent five-year articles
Chao Fu, Hongsen Chen, Yifan Chen, Wenbin Liu, Guangwen Cao
Hepatoma Research.2024;[Epub] CrossRef
The Impact of Radiation Dose and Tumour Burden on Outcomes in Hepatocellular Carcinoma: 11-Year Experience in a 413-Patient Cohort Treated with Yttrium-90 Resin Microsphere Radioembolisation
Kaina Chen, Aaron K.T. Tong, Fiona N.N. Moe, David C.E. Ng, Richard H.G. Lo, Apoorva Gogna, Sean X. Yan, Sue Ping Thang, Kelvin S.H. Loke, Nanda Karaddi Venkatanarasimha, Hian Liang Huang, Chow Wei Too, Timothy S.K. Ong, Eng Xuan Yeo, Daniel Yang Yao Peh,
Liver Cancer.2024; : 1. CrossRef
Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein throm
Jin Hyoung Kim, Gun Ha Kim, Dong Il Gwon
Clinical and Molecular Hepatology.2024; 30(4): 659. CrossRef
Unexpected Anti-tumor Effect of Selective Internal Radiation Therapy and Radiofrequency Ablation Followed by Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Mingzhi Hao, Hai Lan Lin, Yubin Hu, Qizhong Chen, Zhangxian Chen, Linbin Qiu, Duanyu Lin, Hui Zhang, Zuting Fang, Jingfeng Liu
Hepatitis Monthly.2024;[Epub] CrossRef

8,078 View
272 Download
13 Web of Science
Crossref

Reviews

Hepatic neoplasm

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma: Edward Wolfgang Lee, Sarah Khan; Clin Mol Hepatol 2017;23(4):265-272.
Published online November 8, 2017; DOI: https://doi.org/10.3350/cmh.2017.0111

Abstract
PDF

Management of hepatocellular carcinoma (HCC) can be maximized with the utilization of multiple treatment modalities including transplant, surgical resection and locoregional therapies including ablative therapies and transarterial embolotherapies. Although transplant and surgical resection offer the best clinical outcomes, a limited number of patients are amenable to these surgical treatment options due to the advanced disease at presentation. Transarterial embolotherapies including conventional transarterial chemoembolization (cTACE), bland transarterial embolization (TAE), drug-eluting beads transarterial chemoembolization (DEB-TACE) and selective internal radiation therapy (SIRT) with Yttrium 90 (⁹⁰Y) have played an increasingly important role for these patients with unresectable HCC. With a better understanding of different transarterial embolotherapies, more personalized and precise treatment should be implemented for these patients with unresectable HCC. In this review, the updated evidence on the current role of each embolotherapy in the treatment of HCC is summarized.

Citations

Citations to this article as recorded by

Current Status and Progress of Hepatic Artery Perfusion Chemotherapy and Hepatic Artery Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma
少奇祖
Advances in Clinical Medicine.2025; 15(02): 826. CrossRef
Assessing the Validity of the AASLD Surgical Treatment Algorithm in Patients with Early-Stage Hepatocellular Carcinoma
Aryoung Kim, Byeong Geun Song, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Myung Ji Goh, Dong Hyun Sinn
Gut and Liver.2025; 19(2): 265. CrossRef
The prognostic value of mitogen-activated protein kinase kinase in liver hepatocellular carcinoma by bioinformatics
Shen Dong, Shen Jing, Jiao Qinshun, Wang Huaning, Zhu Rong
Medicine.2025; 104(26): e42933. CrossRef
Viral oncogenesis and immune remodeling: Decoding the therapeutic potential of immune checkpoint inhibitors in virus-associated cancers
Lihua Qi, Bai Hu, Canhui Cao, Ting Peng, Miaochun Xu, Shiyi Liu, Yashi Xu, Xiaojie Liu, Wencheng Ding, Li Li, Shitong Lin
Biomedicine & Pharmacotherapy.2025; 191: 118515. CrossRef
Comparative study between Embosphere® and Marine gel® as embolic agents for chemoembolization of hepatocellular carcinoma
Hyo-Cheol Kim, Jin Woo Choi
World Journal of Gastrointestinal Oncology.2024; 16(1): 102. CrossRef
The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients
Jing Long, Xin Zhang, Wei Mi, Jianjun Shi, Hongwei Ren, Qiang Wang
Aging.2024;[Epub] CrossRef
Synthesis and characterization of 3-in-1 multifunctional lipiodol-doped Fe3O4@Poly (diallyl isophthalate) microspheres for arterial embolization, chemotherapy, and imaging
Piaoyi Chen, Qinglin Xiao, Zhaoxiong Guo, Wei Liang, Ou Liu, Liteng Lin, Yugang Huang, Kangshun Zhu, Guodong Ye
Biomedical Materials.2024; 19(3): 035011. CrossRef
Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma
Nojan Bajestani, Gavin Wu, Ahmed Hussein, Mina S. Makary
Biomedicines.2024; 12(7): 1432. CrossRef
An In Vitro Comparative Study of Three Drug-Eluting Beads Loaded with Raltitrexed
Enhao Lu, Jun Tie, Lingxiao Liu, Dong Lu, Weifu Lv, Xianyi Sha
Cancer Biotherapy and Radiopharmaceuticals.2023; 38(9): 641. CrossRef
Benefits of stronger Neo‐Minophagen C in acute hepatitis after transarterial chemoembolization therapy for hepatomas
Wen‐Chieh Huang, Yu‐Min Lin, Hsing‐Tao Kuo, Ming‐Jen Sheu, Yin‐Hsun Feng, I‐Che Feng, Chi‐Shu Sun, Ping‐Hsin Hsieh, Poh‐Poo Lim, Chi‐Hsing Chen
Advances in Digestive Medicine.2023; 10(1): 8. CrossRef
Polydopamine-Coated Radiolabeled Microspheres for Combinatorial Radioembolization and Photothermal Cancer Therapy
Manran Wu, Lei Zhang, Kexin Shi, Dongxu Zhao, Weipeng Yong, Lingling Yin, Ruizhe Huang, Guanglin Wang, Gang Huang, Mingyuan Gao
ACS Applied Materials & Interfaces.2023; 15(10): 12669. CrossRef
In vitro comparative study of multimodal imaging nano-assembled microspheres with two clinical drug-eluting beads loaded with doxorubicin
Yiwei He, Tiancheng Xu, Tingting Ding, Yuanchuan Gong, Hui Zeng, Zihan Xi, Yuanxin Ye, Ziyang Song, Ting Pan, Zhewei Zhang, Qian Ma, Lihua Li, Yuqing Zhang, Guoliang Shao
Drug Delivery.2023;[Epub] CrossRef
Clinically Translatable Phosphonated Silica Microspheres for Selective Internal Radiation Therapy of Hepatocellular Carcinoma
Yi Zhou, Jianxian Ge, Yun Gao, Zhe Yang, Mohammad Javad Afshari, Can Chen, Manran Wu, Lei Chen, Shuwang Wu, Guangxin Duan, Jianfeng Zeng, Mingyuan Gao
Small Science.2023;[Epub] CrossRef
Hepatocellular Carcinoma from a Hepatologist's Perspective
Giovanni A. Roldan, Jacquelin Blomker, Elizabeth S. Aby
Seminars in Interventional Radiology.2023; 40(06): 524. CrossRef
Qilian Huaji decoction exerts an anti-cancer effect on hepatocellular carcinoma by upregulating miR-122
Yongsheng ZHOU, Dan ZHAO, Xuejun JIANG, Wen AN, Xiaoping GAO, Qingyong MA
Food Science and Technology.2022;[Epub] CrossRef
Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno‐oncology: A network meta‐analysis of randomized sorafenib‐controlled trials
Jihyun An, Seungbong Han, Ha Il Kim, Ju Hyun Shim
Hepatology Communications.2022; 6(10): 2886. CrossRef
Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study
Dong Hyun Sinn, Hye Won Lee, Yong-Han Paik, Do Young Kim, Yoon Jun Kim, Kang Mo Kim, Si Hyun Bae, Ji Hoon Kim, Yeon Seok Seo, Jae Young Jang, Byoung Kuk Jang, Hyung Joon Yim, Hyung Joon Kim, Byung Seok Lee, Bo Hyun Kim, In Hee Kim, Eun-Young Cho, Jung Il
Digestive Diseases and Sciences.2021; 66(1): 315. CrossRef
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study
Hye Kyung Hyun, Eun Ju Cho, Soo Young Park, Young Mi Hong, Soon Sun Kim, Hwi Young Kim, Nae-Yun Heo, Jung Gil Park, Dong Hyun Sinn, Wonseok Kang, Song Won Jeong, Myeong Jun Song, Hana Park, Danbi Lee, Yong Sun Lee, Sung Bum Cho, Chan Sik An, Hyung Jin Rhe
Digestive Diseases and Sciences.2021; 66(7): 2427. CrossRef
Delivery of Nanoconstructs in Cancer Therapy: Challenges and Therapeutic Opportunities
Wen Shang Saw, Theebaa Anasamy, Yiing Yee Foo, Yee Chu Kwa, Chin Siang Kue, Chai Hong Yeong, Lik Voon Kiew, Hong Boon Lee, Lip Yong Chung
Advanced Therapeutics.2021;[Epub] CrossRef
Optimized Loading of Idarubicin in CalliSpheres® Drug-Eluting Beads and Characterization of Release Profiles and Morphological Properties
Enhao Lu, Guoliang Shao, Jingqin Ma, Yiwei He, Yuanchuan Gong, Zhiping Yan, Xianyi Sha
Pharmaceutics.2021; 13(6): 799. CrossRef
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Cancers.2021; 14(1): 67. CrossRef
Procedural description and prospective evaluation of short-term outcome for the use of prostatic artery embolization in dogs with carcinoma of the prostate
William T. N. Culp, Eric G. Johnson, Michelle A. Giuffrida, Carrie A. Palm, Katherine A. Skorupski, Jenna H. Burton, Robert B. Rebhun, Jennifer L. Willcox, Michael S. Kent, Carlos O. Rodriguez, Craig B. Glaiberman
Journal of the American Veterinary Medical Association.2021; 259(10): 1154. CrossRef
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Current Oncology.2021; 28(1): 965. CrossRef
Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial
Beom Kyung Kim, Do Young Kim, Hwa Kyung Byun, Hye Jin Choi, Seung-Hoon Beom, Hye Won Lee, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Jinsil Seong, Kwang-Hyub Han
International Journal of Radiation Oncology*Biology*Physics.2020; 107(1): 106. CrossRef
Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B
Jeong-Ju Yoo, Su Jong Yu, Bora Lee, Eun Ju Cho, Jeong-Hoon Lee, Sang Gyune Kim, Yoon Jun Kim, Young Seok Kim, Jung-Hwan Yoon
Gut and Liver.2020; 14(3): 377. CrossRef
A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function
Joon Yeul Nam, A Reum Choe, Dong Hyun Sinn, Jeong-Hoon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Jeong Min Lee, Jin Wook Chung, Sun Young Choi, Jeong Kyong Lee, Seung Yon Baek, Hye Ah Lee, Tae Hun Kim, Kwon Yoo
BMC Cancer.2020;[Epub] CrossRef
Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell
Cancers.2020; 12(7): 1914. CrossRef
Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update
Sirish A. Kishore, Raazi Bajwa, David C. Madoff
Cancers.2020; 12(4): 791. CrossRef
Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
Min Young Baek, Jeong-Ju Yoo, Soung Won Jeong, Jae Young Jang, Yong Kwon Kim, Shin Ok Jeong, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim, Su Yeon Park
The Korean Journal of Internal Medicine.2019; 34(6): 1223. CrossRef
Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model
Eun Ju Cho, Su Jong Yu, Kyungmin Kim, Heki Cho, Young Youn Cho, Yun Bin Lee, Jeong-Hoon Lee, Yoon Jun Kim, Hyewon Youn, Jung-Hwan Yoon
Journal of Bioenergetics and Biomembranes.2019; 51(2): 121. CrossRef
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Young Eun Chon, Hana Park, Hye Kyung Hyun, Yeonjung Ha, Mi Na Kim, Beom Kyung Kim, Joo Ho Lee, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Seong Gyu Hwang, Kwang-Hyub Han, Kyu Sung Rim, Jun Yong Park
Cancers.2019; 11(4): 509. CrossRef
Yttrium-90 Radioembolization: Current Clinical Practice and Review of the Recent Literature
Tatulya Tiwari, Christopher Malone, Gretchen Foltz, Olaguoke Akinwande, Raja S. Ramaswamy
Journal of Radiology Nursing.2019; 38(2): 86. CrossRef
Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis
David Sooik Kim, Tae Seop Lim, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Oidov Baatarkhuu, Seung Up Kim
Digestive Diseases and Sciences.2019; 64(12): 3660. CrossRef
Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression
Yu Young Joo, Jeong Won Jang, Sung Won Lee, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Scientific Reports.2019;[Epub] CrossRef
Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review
Nicolas Voizard, Milena Cerny, Anis Assad, Jean-Sébastien Billiard, Damien Olivié, Pierre Perreault, Ania Kielar, Richard K. G. Do, Takeshi Yokoo, Claude B. Sirlin, An Tang
Insights into Imaging.2019;[Epub] CrossRef
Novel Albumin–Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Jung Hee Kim, Dong Hyun Sinn, Jeong-Hoon Lee, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Young Chang, Yoon Jun Kim, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi
Digestive Diseases and Sciences.2018; 63(4): 1062. CrossRef
Falciform Ligament Artery Uptake on 99mTc MAA Planning Scan Before 90Y SIRT Confirmed by Retrospective SPECT/MRI Fusion
Nils Große Hokamp, Carsten Kobe, James K. O’Donnell, Amit Gupta
Clinical Nuclear Medicine.2018; 43(7): 522. CrossRef
Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor
Song Yi Lee, Jin Woo Choi, Jae-Young Lee, Dae-Duk Kim, Hyo-Cheol Kim, Hyun-Jong Cho
Drug Delivery.2018; 25(1): 1472. CrossRef
Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice of Hepatocarcinoma Xenograft
XiaoXiao Yu, Xue-Jun Lin, Shuang Wang, XiuHong Liu, WeiHua Li, Bu-Xin Kou, MengYin Chai, DeXi Chen, XiaoNi Liu, XiaoJun Wang
Integrative Cancer Therapies.2018; 17(4): 1216. CrossRef
Practical Fingerprinting Localization for Indoor Positioning System by Using Beacons
Santosh Subedi, Jae-Young Pyun
Journal of Sensors.2017; 2017: 1. CrossRef

14,834 View
367 Download
40 Web of Science
Crossref

Hepatic neoplasm

Radioembolization for the treatment of hepatocellular carcinoma: Hyo-Cheol Kim; Clin Mol Hepatol 2017;23(2):109-114.
Published online May 10, 2017; DOI: https://doi.org/10.3350/cmh.2017.0004

Abstract
PDF

Transarterial radioembolization (TARE) with yttrium 90 (⁹⁰Y), an intra-arterial procedure performed by interventional radiologists, has begun being utilized in managing hepatocellular carcinoma (HCC) in Korea. There are two available TARE products: glass and resin microspheres with different physical characteristics. All patients undergoing TARE must be assessed with clinical examination and laboratory tests as well as a thorough angiographic evaluation. TARE is safe and effective in the treatment of unresectable HCC, as it has longer time-to-progression, greater ability to downsize tumors for liver transplantation, less post-embolization syndrome, and shorter hospitalization compared with chemoembolization. TARE can also serve as an alternative to ablation, surgical resection, portal vein embolization, and sorafenib. The utility of TARE continues to expand with new insights in interventional oncology.

Citations

Citations to this article as recorded by

Turning Waste into Treasure: Radiation Byproduct-Induced Fe(III)/Fe(II) Conversion for Efficient Ferroptosis to Improve Iodine-131-Based Transarterial Radioembolization for Liver Tumors
Jiangnan Xu, Xiu Luo, Weiwei Su, Guorong Jia, Huawei Cai, Danni Li, Rou Li, Xiangdong Wang, Yefa Yang, Tao Wang, Changjing Zuo
ACS Applied Materials & Interfaces.2025; 17(20): 29170. CrossRef
Complications of transarterial radioembolization in hepatic malignancies: Pathophysiological insights and management paradigms
Mengdi Qi, Zijia Tao, Duo Yu, Yang Zuo, Hongshan Zhong
European Journal of Radiology.2025; 190: 112224. CrossRef
Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma
Hong Wei, Hanyu Jiang, Jeongin Yoo, Jae Hyun Kim, Hyo-Jin Kang, Yuanan Wu, Rongbo Liu, Hyo-Cheol Kim, Jeong Min Lee
European Radiology.2025; 35(11): 7349. CrossRef
Microporous 3D bioprinting: a novel technology for biofabrication
Hongxiang Cai, Yongrui Cai, Zichuan Ding, Jiaxuan Fan, Yahao Lai, Chao Huang, Boyi Jiang, Can Zhou, Zongke Zhou, Xingcai Zhang, Zeyu Luo
Bio-Design and Manufacturing.2025; 8(5): 847. CrossRef
Assessment of Preprocedural Factors Associated with 5-Year Complete Response After Transarterial Radioembolization in Patients with Hepatocellular Carcinoma
June Park, Dong Kyu Kim, Seungsoo Lee, Shin Hye Hwang
Diagnostics.2025; 15(18): 2297. CrossRef
Radioembolization for hepatocellular carcinoma
Yoselin Dos Santos Poleo, Abrahams Ocanto Martínez
Revisiones en Cáncer.2025;[Epub] CrossRef
Disphosphate based hydrogel microspheres for targeted transarterial radioembolization and chemoembolization therapies
Xuexiao Li, Binyan Zhong, Nan Jiang, Jintao Huang, Di Hu, Ruoran Zhou, Jianfeng Zeng, Wenmiao Shu, Guangxin Duan, Shuwang Wu, Ling Wen
Journal of Advanced Research.2025;[Epub] CrossRef
Overcoming drug resistance microspheres combined with photothermal ablation reinforce transcatheter arterial chemoembolization of hepatocellular carcinoma
Jiheng Shan, Chengzhi Zhang, Yiming Liu, Bingtong Yue, Bin Han, Jing Li, Guodun Zheng, Kunpeng Wu, Huijuan Wu, Yiran Wang, Qingqing He, Xiaonan Shan, Zongming Li, Ping Wu, Kewei Ren, Zhen Li, Jianzhuang Ren, Linyong Du, Yanan Zhao, Xinwei Han
Communications Materials.2025;[Epub] CrossRef
PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: Anthropomorphic phantom study
Anna Budzyńska, Agata Kubik, Krzysztof Kacperski, Patrycja Pastusiak, Michał Kuć, Piotr Piasecki, Marcin Konior, Michał Gryziński, Mirosław Dziuk, Edward Iller, Alexander Hohn
PLOS ONE.2024; 19(2): e0271711. CrossRef
Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment
Fei Feng, Yue Zhao
Medical Principles and Practice.2024; 33(5): 414. CrossRef
Amidoxime-based radio-microspheres for Internal Irradiation combined with a checkpoint-blocking nanobody boost antitumor immunity
Zhenwen Zhao, Yulun Chen, Hui Liu, Haitian Tang, Minglei Teng, Xue Liu, Jianlin Ge, Shilong Shao, Zhenjie Li, Tao Jiang, Chao Liu, Xiao Xu, Gang Liu
Nano Today.2024; 57: 102383. CrossRef
Radioembolization for hepatocellular carcinoma: updated strategies and evolving clinical applications
Jirapa Chansangrat, Sameer Gadani
Hepatoma Research.2024;[Epub] CrossRef
3D Hollow Porous Radio‐Granular Hydrogels for SPECT Imaging‐Guided Cancer Intravascular Brachytherapy
Xiao Xu, Hu Chen, Pan He, Zhenwen Zhao, Xing Gao, Chao Liu, Hongwei Cheng, Lai Jiang, Peiyu Wang, Yang Zhang, Xiaofei Wen, Yesen Li, Jinxiong Huang, Yongfu Xiong, Jingsong Mao, Hongjuan Ma, Gang Liu
Advanced Functional Materials.2023;[Epub] CrossRef
Microspheres as a Carrier System for Therapeutic Embolization Procedures: Achievements and Advances
Mick. M. Welling, Nikolas Duszenko, Maarten P. van Meerbeek, Tom J. M. Molenaar, Tessa Buckle, Fijs W. B. van Leeuwen, Daphne D. D. Rietbergen
Journal of Clinical Medicine.2023; 12(3): 918. CrossRef
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
Sung Won Chung, Heejin Cho, Hyunjae Shin, Jeayeon Park, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Myungsu Lee, Yoon Jun Kim, Jin Chul Paeng, Jung-Hwan Yoon, Jin Wook Chung, Jeong-Hoon Lee, Hyo-Cheol Kim
Frontiers in Oncology.2023;[Epub] CrossRef
Post-embolization Syndrome Following Yttrium-90 Radiation Segmentectomy
Naisarg B Vanani, Abhishek Janardan, Nisar Asmi, Pinky Jha
Cureus.2023;[Epub] CrossRef
Radio-granular hydrogels for image-guided tumor brachytherapy
Shilong Shao, Xiao Xu, Gan Lin, Gang Liu
iLIVER.2023; 2(3): 177. CrossRef
A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC
Joon Yeul Nam, Yun Bin Lee, Jeong-Hoon Lee, Su Jong Yu, Hyo-Cheol Kim, Jin Wook Chung, Jung-Hwan Yoon, Yoon Jun Kim
Digestive Diseases and Sciences.2022; 67(1): 329. CrossRef
Facile preparation of 177Lu-microspheres for hepatocellular carcinoma radioisotope therapy
Manran Wu, Kexin Shi, Ruizhe Huang, Chunyi Liu, Lingling Yin, Weipeng Yong, Jing Sun, Guanglin Wang, Zhiyuan Zhong, Mingyuan Gao
Chinese Chemical Letters.2022; 33(7): 3492. CrossRef
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients
Sun Young Yim, Ho Soo Chun, Jae Seung Lee, Ji-Hwan Lim, Tae Hyung Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Gyoung Min Kim, Jong Yun Won, Yeon Seok Seo, Yun Hwan Kim, Soon Ho Um, Do Young Kim
Cancers.2022; 14(2): 385. CrossRef
Development of neutron-activated samarium-153-loaded polystyrene microspheres as a potential theranostic agent for hepatic radioembolization
Hun Yee Tan, Yin How Wong, Azahari Kasbollah, Mohammad Nazri Md Shah, Basri Johan Jeet Abdullah, Alan Christopher Perkins, Chai Hong Yeong
Nuclear Medicine Communications.2022; 43(4): 410. CrossRef
Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma
Shaohua Li, Min Deng, Qiaoxuan Wang, Jie Mei, Jingwen Zou, Wenping Lin, Ming Shi, Minshan Chen, Wei Wei, Rongping Guo, Bruno Vincenzi
Journal of Oncology.2022; 2022: 1. CrossRef
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study
Eleni Gkika, Anca-Ligia Grosu, Teresa Macarulla Mercade, Antonio Cubillo Gracián, Thomas B. Brunner, Michael Schultheiß, Monika Pazgan-Simon, Thomas Seufferlein, Yann Touchefeu
Cancers.2022; 14(6): 1568. CrossRef
Radioembolization for hepatocellular carcinoma: what clinicians need to know
Jin Woo Choi, Hyo-Cheol Kim
Journal of Liver Cancer.2022; 22(1): 4. CrossRef
Case Report: Massive Hepatocellular Carcinoma Complete Surgical Resection After Portal Vein Embolization and Multimodality Therapy
Qianyi Lin, Dexiong Chen, Kangde Li, Xiaomin Fan, Qi Cai, Weihong Lin, Chunhong Qin, Tao He
Frontiers in Radiology.2022;[Epub] CrossRef
Association of dysmorphic intratumoral vessel with high lung shunt fraction in patients with hepatocellular carcinoma
Tae Won Choi, Ijin Joo, Hyo-Cheol Kim
Scientific Reports.2022;[Epub] CrossRef
Radiochemical Feasibility of Mixing of 99mTc-MAA and 90Y-Microspheres with Omnipaque Contrast
Chang-Tong Yang, Pei Ing Ngam, Vanessa Jing Xin Phua, Sidney Wing Kwong Yu, Gogna Apoorva, David Chee Eng Ng, Hian Liang Huang
Molecules.2022; 27(21): 7646. CrossRef
Theranostic approach in liver cancer: an emerging paradigm to optimize personalized medicine
Narges Jokar, Farzad Moradhaseli, Hojjat Ahmadzadehfar, Esmail Jafari, Saman Nikeghbalian, Ali Reza Rasekhi, Majid Assadi
Clinical and Translational Imaging.2022; 11(1): 51. CrossRef
Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study
Dong Hyun Sinn, Hye Won Lee, Yong-Han Paik, Do Young Kim, Yoon Jun Kim, Kang Mo Kim, Si Hyun Bae, Ji Hoon Kim, Yeon Seok Seo, Jae Young Jang, Byoung Kuk Jang, Hyung Joon Yim, Hyung Joon Kim, Byung Seok Lee, Bo Hyun Kim, In Hee Kim, Eun-Young Cho, Jung Il
Digestive Diseases and Sciences.2021; 66(1): 315. CrossRef
Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization
Yuyi Qian, Qiufang Liu, Panli Li, Yaobao Han, Jianping Zhang, Jiaojiao Xu, Jingwen Sun, Aihua Wu, Shaoli Song, Wei Lu
ACS Nano.2021; 15(2): 2933. CrossRef
Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention
Joseph H. Yacoub, David Mauro, Andrew Moon, Aiwu R. He, Mustafa R. Bashir, Christine C. Hsu, Thomas M. Fishbein, Lauren M. B. Burke
Abdominal Radiology.2021; 46(8): 3540. CrossRef
LI-RADS Version 2018 Treatment Response Algorithm: Diagnostic Performance after Transarterial Radioembolization for Hepatocellular Carcinoma
Jongjin Yoon, Sunyoung Lee, Jaeseung Shin, Seung-seob Kim, Gyoung Min Kim, Jong Yun Won
Korean Journal of Radiology.2021; 22(8): 1279. CrossRef
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Current Oncology.2021; 28(1): 965. CrossRef
Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study
Minseok Albert Kim, Heejoon Jang, Na Ryung Choi, Joon Yeul Nam, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Hyo-Cheol Kim, Jin Wook Chung, Jung-Hwan Yoon, Yoon Jun Kim
Journal of Hepatocellular Carcinoma.2021; Volume 8: 1565. CrossRef
Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma
Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli
Cancers.2021; 13(17): 4387. CrossRef
Antitumor Effects of Triterpenes in Hepatocellular Carcinoma
Antoni Sureda, Miquel Martorell, Xavier Capó, Margalida Monserrat-Mesquida, Maria Magdalena Quetglas-Llabrés, Mahsa Rasekhian, Seyed M. Nabavi, Silvia Tejada
Current Medicinal Chemistry.2021; 28(13): 2465. CrossRef
Preparation and characterization of inorganic radioactive holmium-166 microspheres for internal radionuclide therapy
A.G. Arranja, W.E. Hennink, C. Chassagne, A.G. Denkova, J.F.W. Nijsen
Materials Science and Engineering: C.2020; 106: 110244. CrossRef
Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization
Jae Seung Lee, Han Ah Lee, Mi Young Jeon, Tae Seop Lim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Soon Ho Um, Kwang-Hyub Han, Yeon Seok Seo, Seung Up Kim
European Journal of Gastroenterology & Hepatology.2020; 32(6): 739. CrossRef
Association between objective response rate and overall survival in metastatic neuroendocrine tumors treated with radioembolization: a systematic literature review and regression analysis
Richard F Pollock, Victoria K Brennan, Ralph Peters, Philipp M Paprottka
Expert Review of Anticancer Therapy.2020; 20(11): 997. CrossRef
The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
Jae Seung Lee, Hong Jun Choi, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Song-Ee Baek, Yong Eun Chung, Mi-Suk Park, Myeong-Jin Kim, Hyungjin Rhee, Seung Up Kim
Gut and Liver.2020; 14(6): 765. CrossRef
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage
Alberta Cappelli, Paloma Sangro, Cristina Mosconi, Iris Deppe, Eleonora Terzi, Jose I. Bilbao, Macarena Rodriguez-Fraile, Caterina De Benedittis, Jens Ricke, Rita Golfieri, Bruno Sangro
European Journal of Nuclear Medicine and Molecular Imaging.2019; 46(3): 661. CrossRef
Feasibility of Boosted Radioembolization for Hepatocellular Carcinoma Larger than 5 cm
Hyo-Cheol Kim, Yoon Jun Kim, Jeong-Hoon Lee, Kyung-Suk Suh, Jin Wook Chung
Journal of Vascular and Interventional Radiology.2019; 30(1): 1. CrossRef
Expected and Unexpected Imaging Findings after 90Y Transarterial Radioembolization for Liver Tumors
Juan C. Spina, Isabel Hume, Ana Pelaez, Oscar Peralta, Marcos Quadrelli, Ricardo Garcia Monaco
RadioGraphics.2019; 39(2): 578. CrossRef
Designing pH-triggered drug release iron oxide nanocomposites for MRI-guided photothermal-chemoembolization therapy of liver orthotopic cancer
Fengyong Liu, Xin Li, Yangyang Li, Yuchen Qi, Hongjun Yuan, Jian He, Wanlin Li, Min Zhou
Biomaterials Science.2019; 7(5): 1842. CrossRef
Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System
Sonal Krishan, Radha K. Dhiman, Navin Kalra, Raju Sharma, Sanjay S. Baijal, Anil Arora, Ajay Gulati, Anu Eapan, Ashish Verma, Shyam Keshava, Amar Mukund, S. Deva, Ravi Chaudhary, Karthick Ganesan, Sunil Taneja, Ujjwal Gorsi, Shivanand Gamanagatti, Kumble
Journal of Clinical and Experimental Hepatology.2019; 9(5): 625. CrossRef
Intravoxel Incoherent Motion Parameters for Assessing the Efficiency of Locoregional Bridging Treatments before Liver Transplantation
Sadık Server, Soheil Sabet, Refik Bilgin, Nagihan Inan, Yıldıray Yuzer, Yaman Tokat
Transplantation Proceedings.2019; 51(7): 2391. CrossRef
Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know
Ijin Joo, Hyo-Cheol Kim, Gyoung Min Kim, Jin Chul Paeng
Korean Journal of Radiology.2018; 19(2): 209. CrossRef
Yttrium-90 Radioembolization of the Right Inferior Phrenic Artery in 20 Patients with Hepatocellular Carcinoma
Hyo-Cheol Kim, Yoon Jun Kim, Jin Chul Paeng, Jin Wook Chung
Journal of Vascular and Interventional Radiology.2018; 29(4): 556. CrossRef
Treatment of Hepatocellular Carcinoma: A Cost Analysis Of Yttrium-90 Transarterial Radioembolization Versus Sorafenib
Maria Grazia Lucà, Roberto Nani, Melanie Schranz, Massimo De Giorgio, Claudia Iegri, Roberto Agazzi, Francesco Sala, Giorgio Virotta, Donatella Sarti, Grazia Conte, Domenico Pinelli, Carlo Nicora, Michele Colledan, Sandro Sironi, Stefano Fagiuoli
Future Oncology.2018; 14(8): 727. CrossRef
Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor
Song Yi Lee, Jin Woo Choi, Jae-Young Lee, Dae-Duk Kim, Hyo-Cheol Kim, Hyun-Jong Cho
Drug Delivery.2018; 25(1): 1472. CrossRef
Hepatocellular carcinoma treatment: hurdles, advances and prospects
Ratna Kumari, Manoj Kumar Sahu, Anindita Tripathy, Kanishka Uthansingh, Manas Behera
Hepatic Oncology.2018;[Epub] CrossRef
Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
Aldona Kasprzak, Agnieszka Adamek
International Journal of Molecular Sciences.2018; 19(12): 3887. CrossRef

15,676 View
382 Download
56 Web of Science
Crossref

Case Report

Hepatic neoplasm

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with ⁹⁰Y microspheres: Sun Young Yim, Jin Dong Kim, Jin Yong Jung, Chang Ha Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Ho Sang Ryu, Yun Hwan Kim, Chong Suk Kim, Eun Shin; Clin Mol Hepatol 2014;20(3):300-305.
Published online September 25, 2014; DOI: https://doi.org/10.3350/cmh.2014.20.3.300

Abstract
PDF

Transcatheter arterial radioembolization (TARE) with Yttrium-90 (⁹⁰Y)-labeled microspheres has an emerging role in treatment of patients with unresectable hepatocellular carcinoma. Although complication of TARE can be minimized by aggressive pre-evaluation angiography and preventive coiling of aberrant vessels, radioembolization-induced gastroduodenal ulcer can be irreversible and can be life-threatening. Treatment of radioembolization-induced gastric ulcer is challenging because there is a few reported cases and no consensus for management. We report a case of severe gastric ulceration with bleeding that eventually required surgery due to aberrant deposition of microspheres after TARE.

Citations

Citations to this article as recorded by

An Uncommon Case of Severe Gastric Ulceration Following Radioembolization for Hepatocellular Carcinoma: Clinical Insights and Management Challenges
Saad Aldosari, Ahmad A Alsolmi, Abdullah Alsulami, Nawaf Halabi, Fatimah Alturkistani
Cureus.2025;[Epub] CrossRef
Extrahepatic 90Y Complication; Gastric Ulcer Secondary to 90Y Therapy for Liver Metastasis Despite Negative Preprocedural Imaging
Connor Shea, Hannah Lamberg, Sevcan Turk, Mamadou Sanogo, Danielle Turgeon, Broko Nojkov, Kirk Frey, David Raffel
Nuclear Medicine and Molecular Imaging.2024; 58(2): 86. CrossRef
Transcatheter Arterial Radioembolization–Induced Gastric Ulcer in an Excluded Stomach After Roux-en-Y Gastric Bypass
Grace E. Kim, Dennis Chen
ACG Case Reports Journal.2024; 11(7): e01399. CrossRef
Laparoscopic Gastrojejunostomy for the Treatment of SIRT-Induced Duodenal Ulcer Complicated by Gastric Outlet Obstruction
Walaa El Arja, Sarah B. Eid, Elias Saikaly, Lynn Ezzeddine, Rayan Daoud, Elias Fiani
International Journal of Recent Surgical and Medical Sciences.2022; 08(02): 063. CrossRef
Radioembolization for hepatocellular carcinoma: what clinicians need to know
Jin Woo Choi, Hyo-Cheol Kim
Journal of Liver Cancer.2022; 22(1): 4. CrossRef
Therapeutic approach of adipose-derived mesenchymal stem cells in refractory peptic ulcer
Mahshid Saleh, Amir Ali Sohrabpour, Mohammad Reza Mehrabi, Iman Seyhoun, Amir Abbas Vaezi
Stem Cell Research & Therapy.2021;[Epub] CrossRef
90Y-TheraSpheres
Christina A. Arnold, Maryam K. Pezhouh, Dora Lam-Himlin, Meredith E. Pittman, Christopher VandenBussche, Lysandra Voltaggio
American Journal of Surgical Pathology.2019; 43(5): 688. CrossRef
Angiographic Anatomy and Relevance of 3 and 9 O’clock Arteries During Radioembolization
Maciej Powerski, Bartosz Bascik, Jazan Omari, Shahen El-Sanosy, Oliver S. Grosser, Max Seidensticker, Frank Fischbach, Maciej Pech
CardioVascular and Interventional Radiology.2018; 41(6): 890. CrossRef
Yttrium-90

Reactions Weekly.2017; 1648(1): 300. CrossRef
Microvascular injury in persistent gastric ulcers after yttrium-90 microsphere radioembolization for liver malignancies
Belinda Sun, Shawn R. Lapetino, Sameer A.L. Diffalha, Sherri Yong, Ron C. Gaba, James T. Bui, Sean Koppe, Steven Garzon, Grace Guzman
Human Pathology.2016; 50: 11. CrossRef
Long-Term Palliative Effect of Stenting in Gastric Outlet Obstruction Due to Transarterial Chemoembolization with Yttrium-90 in a Patient with Metastatic Neuroendocrine Tumor
Erkan Caglar, Gulen Doğusoy, Levent Kabasakal, Ahmet Dobrucali
Clinical Endoscopy.2016; 49(5): 479. CrossRef
Diagnostic and Treatment Approaches for Refractory Peptic Ulcers
Heung Up Kim
Clinical Endoscopy.2015; 48(4): 285. CrossRef